DYNAVAX TECH (NASDAQ:DVAX)
1.26
0.03 (2.33%)
| DYNAVAX TECH (NASDAQ:DVAX) Delayed : |
| Previous Close |
$1.29 |
|
52 Week High |
$3.35 |
|
| Open |
$1.27 |
|
52 Week Low |
$0.15 |
| Day High |
$1.29 |
|
P/E |
18.00 |
| Day Low |
$1.25 |
|
EPS |
$0.07 |
| Volume |
167,611 |
|
|
|
| More DVAX Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on DVAX
-
Nov 10, 2009 07:28 AM
Dynavax Technologies (DVAX) To Purchase Symphony Dynamo; Will Acquire $20M in Cash and Hep C and Cancer Rights
-
Oct 23, 2009 10:53 AM
Morning Movers 10/23: AMZN, CPWR, EPAY, ALGN, HWAY, SCSS, ACO Higher; ELN, SNV, CBRX, RMTR, STSA, DVAX Lower
-
Oct 22, 2009 04:57 PM
Dynavax Technologies (DVAX) Reports Q3 loss of $0.24
-
Sep 29, 2009 08:40 AM
Dynavax (DVAX) Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine
-
Sep 11, 2009 01:19 PM
Unusual 11 Mid-Day Movers 9/11: NURO, CMRO, ALTI, SPDE Higher; CMZ, QELP, DVAX, HZO Lower
View All Reports
StreetInsider Reports on DVAX by Category
-
Aug 5, 2009 04:37 AM
FDA Calendar Updates: Covidien, Dynavax, Nuvo Research
-
Jul 29, 2009 04:21 AM
Swine Flu Stocks - Just Wait Until Fall
-
Apr 28, 2009 04:47 AM
Dynavax Surge Not Warranted
-
Oct 22, 2008 10:24 AM
Biotech Implosion: Dynavax (DVAX)
-
Oct 22, 2008 07:52 AM
Top Pre-Market Analyst Downgrades (AMP, AAPL, DVAX, FCX, GMT, LNC, PCX, X)
View All Blogs
Comments on recent DVAX articles
Comments on DVAX
No comments are currently available.
on Sep 6, 2009
at 12:01 PM Swine flu Did anyone go to www.swineflustocks.com ? I believe it's up for sale for $50,000. I heard it was purchased not to long ago for $10. Talk about a potential rate of return. Do the math.
Article: Swine Flu Stocks Could Be Hot As Fears Grow and Vaccine Production Put In Motion
on Oct 23, 2008
at 09:43 PM dynavax The US is full of stupid short sighted investors with no business investing in anything, let alone speculative companies doing good for the world like DVAX.
Article: Dynavax (DVAX) Slammed As HEPLISAV Looks Like a Bust in Hep B